An evaluation of CaSR mRNA expression in primary neuroblastic tumors revealed that the receptor expression correlated with good prognostic variables, such as age at diagnosis <1 year, low clinical stage, low clinical risk, and differentiated histology [112]. The gene discussed is CASR; the disease is neuroblastic tumor.